Reduced von Willebrand factor survival in type Vicenza von Willebrand disease.

Type Vicenza variant of von Willebrand disease (VWD) is characterized by a low plasma von Willebrand factor (VWF) level and supranormal VWF multimers. Two candidate mutations, G2470A and G3864A at exons 17 and 27, respectively, of the VWF gene were recently reported to be present in this disorder. Four additional families, originating from northeast Italy, with both mutations of type Vicenza VWD are now described. Like the original type Vicenza subjects, they showed a mild bleeding tendency and a significant decrease in plasma VWF antigen level and ristocetin cofactor activity but normal platelet VWF content. Unlike the original patients, ristocetin-induced platelet aggregation was found to be normal. Larger than normal VWF multimers were also demonstrated in the plasma. Desmopressin (DDAVP) administration increased factor VIII (FVIII) and VWF plasma levels, with the appearance of even larger multimers. However, these forms, and all VWF oligomers, disappeared rapidly from the circulation. The half-life of VWF antigen release and of elimination was significantly shorter than that in healthy counterparts, so that at 4 hours after DDAVP administration, VWF antigen levels were close to baseline. Similar behavior was demonstrated by VWF ristocetin cofactor activity and FVIII. According to these findings, it is presumed that the low plasma VWF levels of type Vicenza VWD are mainly attributed to reduced survival of the VWF molecule, which, on the other hand, is normally synthesized. In addition, because normal VWF-platelet GPIb interaction was observed before or after DDAVP administration, it is proposed that type Vicenza VWD not be considered a 2M subtype.

[1]  E. Missiaglia,et al.  An Additional Unique Candidate Mutation (G2470A; M740I) in the Original Families with von Willebrand Disease Type 2 M Vicenza and the G3864A (R1205H) Mutation , 2000, Thrombosis and Haemostasis.

[2]  R. Lange,et al.  Platelet Glycoprotein IIb/IIIa Receptor Blockade: Lessening the Risk of Coronary Interventions , 1999, Thrombosis and Haemostasis.

[3]  A. Bertomoro,et al.  Which Assay Is the Most Suitable to Investigate von Willebrand Factor Functional Activity ? , 1999, Thrombosis and Haemostasis.

[4]  R. Zimmermann,et al.  New families with von Willebrand disease type 2M (Vicenza). , 1997, Thrombosis research.

[5]  A. Bertomoro,et al.  Abnormal collagen binding activity of 2A von Willebrand factor: evidence that the defect depends only on the lack of large multimers. , 1997, The Journal of laboratory and clinical medicine.

[6]  T. Matsushita,et al.  Molecular Mechanism and Classification of von Willebrand Disease , 1995, Thrombosis and Haemostasis.

[7]  J. Sadler,et al.  A Revised Classification of von Willebrand Disease , 1994, Thrombosis and Haemostasis.

[8]  E. Favaloro,et al.  von Willebrand's disease: Use of collagen binding assay provides potential improvement to laboratory monitoring of desmopressin (DDAVP) therapy , 1994, American journal of hematology.

[9]  P. Mannucci,et al.  The role of platelet von Willebrand factor in platelet adhesion and thrombus formation: a study of 34 patients with various subtypes of type I von Willebrand disease , 1994, British journal of haematology.

[10]  E. Sacchi,et al.  The Genetic Defect of Type I von Willebrand Disease “Vicenza” Is Linked to the von Willebrand Factor Gene , 1993, Thrombosis and Haemostasis.

[11]  D. Mancuso,et al.  von Willebrand disease type B: a missense mutation selectively abolishes ristocetin-induced von Willebrand factor binding to platelet glycoprotein Ib. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[12]  A. Girolami,et al.  Impaired release of tissue plasminogen activator (t‐PA) following DDAVP infusion in von Willebrand's disease with low platelet von Willebrand factor content , 1992, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[13]  J. Sixma,et al.  In vivo experiments indicate that relatively high platelet deposition in von Willebrand's disease 'Vicenza' is caused by normal platelet-VWF levels rather than by high VWF-multimers in plasma. , 1992, Thrombosis research.

[14]  J. Ware,et al.  Identification of a cleavage site directing the immunochemical detection of molecular abnormalities in type IIA von Willebrand factor. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[15]  F. Fabris,et al.  A new congenital platelet abnormality characterized by spontaneous platelet aggregation, enhanced von Willebrand factor platelet interaction, and the presence of all von Willebrand factor multimers in plasma. , 1989, Blood.

[16]  J. Batlle,et al.  The heterogeneity of type IIA von Willebrand's disease: studies with protease inhibitors , 1986 .

[17]  H. Gralnick,et al.  In vitro correction of the abnormal multimeric structure of von Willebrand factor in type IIa von Willebrand's disease. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[18]  F. Fabris,et al.  The evaluation of factor VIII antigen by means of a simple slide test. , 1985, American journal of clinical pathology.

[19]  P. Mannucci,et al.  Multimeric composition of factor VIII/von Willebrand factor following administration of DDAVP: implications for pathophysiology and therapy of von Willebrand's disease subtypes , 1982 .

[20]  Z. Ruggeri,et al.  Variant von Willebrand's disease: characterization of two subtypes by analysis of multimeric composition of factor VIII/von Willebrand factor in plasma and platelets. , 1980, The Journal of clinical investigation.

[21]  P. Mannucci,et al.  Heightened interaction between platelets and factor VIII/von Willebrand factor in a new subtype of von Willebrand's disease. , 1980, The New England journal of medicine.

[22]  R. Scarpa,et al.  A ‘New’ Congenital Haemorrhagic Condition due to the Presence of an Abnormal Factor X (Factor X Friuli): Study of a Large Kindred , 1970, British journal of haematology.

[23]  P. Mannucci,et al.  Von Willebrand Disease Type 2M “Vicenza” in Italian and German Patients: Identification of the First Candidate Mutation (G3864A; R1205H) in 8 Families , 2000, Thrombosis and Haemostasis.

[24]  D. Ginsburg,et al.  Von Willebrand disease. , 2008, Pediatric clinics of North America.

[25]  A. Bertomoro,et al.  A new variant of von Willebrand's disease (type I Padua): doublet-organized plasma von Willebrand factor oligomers in the presence of all size multimers. , 1994, Haematologia.

[26]  F. Rodeghiero,et al.  von Willebrand disease "Vicenza" with larger-than-normal (supranormal) von Willebrand factor multimers. , 1988, Blood.

[27]  A. Federici,et al.  Multimeric composition of factor VIII/von Willebrand factor following administration of DDAVP: implications for pathophysiology and therapy of von Willebrand's disease subtypes. , 1982, Blood.

[28]  H. Gralnick,et al.  Effect of multimeric structure of the factor VIII/von Willebrand factor protein on binding to platelets. , 1981, Blood.